Application of Pinellinoic acid in preparation of medicine for treating constipation-type irritable bowel syndrome

The invention discloses an application of Pinellinoic acid in preparation of a medicine for treating constipation-type irritable bowel syndrome. Compared with the prior art, it is found for the first time that the Tonglingnoic acid can treat the irritable bowel syndrome, especially the constipation type irritable bowel syndrome. Researches prove that the Pinellinoic acid can effectively reduce the content of 5-HT and CGRP in serum, promote defecation and improve constipation symptoms. Therefore, the Pinellinoic acid can be used for preparing the medicine for treating the irritable bowel syndrome, and has good market potential and value. 本发明公开了松苓新酸在制备治疗便秘型肠易激综合征药物中的应用。与现有技术相比，本发明首次发现松苓新酸能够治疗肠易激综合征，尤其是便秘型肠易激综合征。研究证实，松苓新酸能有效降低血清中5-HT和CGRP含量，促进排便，改善便秘症状。因此，松苓新酸能够用于制备治疗肠易激综合征的药物，具备良好的市场潜力和价值。